Statins are often linked to a myriad of side effects, raising questions about their true impact on the body. While some argue these effects stem from the nocebo phenomenon—where negative expectations lead to real symptoms—there's skepticism surrounding this claim. Investigating the funding behind influential studies reveals a troubling connection to the pharmaceutical industry, suggesting that the narrative may be more complex than it appears.
